Q2 Group revenue NOK 856m, -2% vs ARCe & Cons at NOK 872/871mKID revenue NOK 536m, +3%/+1% vs ARCe/Cons. Hemtex revenue NOK 321m, -9/-5% vs ARCe/Cons.16%/3% downside to consensus Q2/2025e EBIT, all else equalNegative, but our key concern is still 10% EPS downside to consensus on higher cost
